Why This Connecticut Biotech Could be a $1M Opportunity for Investors Post author:Sam Post published:January 23, 2018 Post category:BioPharma Could Cara be the answer for investors itching to make $1 million? Source: BioSpace You Might Also Like Argos Cuts Staff by 38% After Devastating Phase III News March 9, 2017 J&J to Spend More on R&D With Tax Reform Money January 23, 2018 Busy Takeda Takes Out Tigenix in $630M Deal January 4, 2018
